SEC Form 4 · accession 0000911916-17-000192
ZIMMER BIOMET HOLDINGS, INC. · ZBH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sang Yi
Officer — President, Asia Pacific
Period of report
Jun 9, 2017
Accepted (ET)
Jun 13, 2017 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001136869
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 9, 2017 | M | 6,097 | $73.15 | A | 10,885 | D | |
| Common Stock | Jun 9, 2017 | M | 3,550 | $74.90 | A | 14,435 | D | |
| Common Stock | Jun 9, 2017 | M | 3,310 | $94.34 | A | 17,745 | D | |
| Common StockF2 | Jun 9, 2017 | S | 6,097 | $124.8599 | D | 11,648 | D | |
| Common StockF3 | Jun 9, 2017 | S | 3,550 | $124.8614 | D | 8,098 | D | |
| Common StockF4 | Jun 9, 2017 | S | 3,310 | $124.864 | D | 4,788 | D | |
| Common Stock | Jun 9, 2017 | S | 474 | $124.9301 | D | 4,314 | D | |
| Common StockF5 | Jun 12, 2017 | S | 4,300 | $123.6157 | D | 14 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F6 | $73.15 | Jun 9, 2017 | M | 6,097 | D | — | Mar 18, 2023 | Common Stock | 6,097 | 0 | D |
| Employee Stock Option (right to buy)F7 | $74.90 | Jun 9, 2017 | M | 3,550 | D | — | Apr 1, 2023 | Common Stock | 3,550 | 0 | D |
| Employee Stock Option (right to buy)F8 | $94.34 | Jun 9, 2017 | M | 3,310 | D | — | Mar 17, 2024 | Common Stock | 3,310 | 1,655 | D |
Explanation of responses
- F1Includes 1 share acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan on May 1, 2017 and 6 shares purchased on April 28, 2017 under the dividend reinvestment plan for the Company's common stock.
- F2Represents the sale of 6,097 shares in multiple transactions ranging in price from $124.40 to $125.33 per share, resulting in a weighted average sale price of $124.8599. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F3Represents the sale of 3,550 shares in multiple transactions ranging in price from $124.40 to $125.33 per share, resulting in a weighted average sale price of $124.8614. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F4Represents the sale of 3,310 shares in multiple transactions ranging in price from $124.42 to $125.30 per share, resulting in a weighted average sale price of $124.864. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F5Represents the sale of 4,300 shares in multiple transactions ranging in price from $123.415 to $123.72 per share, resulting in a weighted average sale price of $123.6157. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F63,049 options vested on March 18, 2016; and 3,048 options vested on March 18, 2017.
- F71,775 options vested on each of April 1, 2016 and 2017.
- F81,655 options vested on each of March 17, 2016 and 2017; and the remaining 1,655 of the options are scheduled to vest on March 17, 2018.